(Q51307303)

3 April 2018

title

Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome. (English)

1 reference

3 April 2018

0 references

1 reference

1 reference

1 reference

Mitra Nourbakhsh

1

1 reference

3 April 2018

Mona Nourbakhsh

series ordinal

2

1 reference

3 April 2018

Zafar Gholinejad

series ordinal

3

1 reference

3 April 2018

Maryam Razzaghy-Azar

series ordinal

4

1 reference

3 April 2018

publication date

27 February 2015

1 reference

3 April 2018

Scandinavian Journal of Clinical and Laboratory Investigation

published in

1 reference

3 April 2018

volume

75

1 reference

3 April 2018

issue

2

1 reference

3 April 2018

page(s)

183-188

1 reference

3 April 2018

Adipokines in inflammation and metabolic disease

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

What is metabolic syndrome, and why are children getting it?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Adipose tissue, inflammation, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Visfatin and its role in obesity development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Retraction: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

The release of the adipocytokine visfatin is regulated by glucose and insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Assessment of insulin sensitivity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Childhood obesity and adult morbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Serum visfatin levels, adiposity and glucose metabolism in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Trend in the prevalence of obesity and overweight among Iranian children and adolescents: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Proinflammatory cytokines and leptin are increased in serum of prepubertal obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

The Role of PAI-1 and Adiponectin on the Inflammatory State and Energy Balance in Obese Adolescents with Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2014.1003594

10.3109/00365513.2014.1003594

21 January 2018

Identifiers

DOI

1 reference

3 April 2018

PubMed ID

25723377

1 reference

3 April 2018